Potential drug–drug interactions of oral systemic therapies for psoriasis have adverse outcomes in a real-world setting

P201

  • Saurat, Jean-Hilaire
  • Guérin, Annie
  • Mulani, Parvez
  • Gupta, Shiraz

  • 1Hôpital Cantonal Universitaire de Genève, Geneva, Switzerland

    2Analysis Group, Boston, MA, United States

    3Abbott Laboratories, Abbott Park, IL, United States

    4Abbott Laboratories, Abbott Park, IL, United States

Commercial support: This study is sponsored by Abbott Laboratories.

Journal of the American Academy of Dermatology 62(3):p AB3, March 2010.
Copyright © 2010 by Mosby, Inc.